Abstract
Indications for transcatheter aortic valve implantation (TAVI) have expanded in many countries to include patients with aortic stenosis who are at low surgical risk, and a similar expansion to this cohort is anticipated elsewhere in the world, together with an increase in the proportion of patients with bicuspid aortic valve (BAV) morphology as the age of the patients being treated decreases. To date, patients with BAV have been excluded from major randomized trials of TAVI owing to anatomical considerations. As a consequence, BAV has been a relative contraindication to the use of TAVI in international guidelines. Although clinical experience and observational data are accumulating, BAV presents numerous anatomical challenges for successful TAVI, despite advances in device design. Furthermore, in those with BAV, substantial geographical variation exists in patient characteristics, clinical approach and procedural strategy. Therefore, in this Roadmap article, we summarize the existing evidence and provide consensus recommendations from an international group of experts on the application of TAVI in patients with BAV in advance of the anticipated growth in the use of this procedure in this challenging cohort of patients.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Roberts, W. C. & Ko, J. M. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111, 920–925 (2005).
Sievers, H.-H. & Schmidtke, C. A classification system for the bicuspid aortic valve from 304 surgical specimens. J. Thorac. Cardiovasc. Surg. 133, 1226–1233 (2007).
Waksman, R. et al. Transcatheter aortic valve replacement in low-risk patients with symptomatic severe bicuspid aortic valve stenosis. JACC Cardiovasc. Interv. 13, 1019–1027 (2020).
Vincent, F. et al. Transcatheter aortic valve replacement in bicuspid aortic valve stenosis. Circulation 143, 1043–1061 (2021).
The Millennium Project. The real-time Delphi. http://www.millennium-project.org/rtd-general/ (2017).
Kochman, J., Rymuza, B. & Huczek, Z. Transcatheter aortic valve replacement in bicuspid aortic valve disease. Curr. Opin. Cardiol. 30, 594–602 (2015).
Popma, J. J. & Ramadan, R. CT Imaging of bicuspid aortic valve disease for TAVR. JACC Cardiovasc. Imaging 9, 1159–1163 (2016).
Yoon, S.-H. et al. Bicuspid aortic valve morphology and outcomes after transcatheter aortic valve replacement. J. Am. Coll. Cardiol. 76, 1018–1030 (2020).
Kong, W. K. F., Delgado, V. & Bax, J. J. Bicuspid aortic valve: what to image in patients considered for transcatheter aortic valve replacement? Circ. Cardiovasc. Imaging 10, e005987 (2017).
Sinning, C. et al. Bicuspid aortic valve and aortic coarctation in congenital heart disease — important aspects for treatment with focus on aortic vasculopathy. Cardiovasc. Diagn. Ther. 8, 780–788 (2018).
Tchetche, D. et al. Bicuspid aortic valve anatomy and relationship with devices: the BAVARD multicenter registry. Circ. Cardiovasc. Interv. 12, e007107 (2019).
Boccalini, S. et al. Bicuspid aortic valve annulus: assessment of geometry and size changes during the cardiac cycle as measured with a standardized method to define the annular plane. Eur. Radiol. 31, 8116–8129 (2021).
Kawamori, H. et al. Computed tomography characteristics of the aortic valve and the geometry of SAPIEN 3 transcatheter heart valve in patients with bicuspid aortic valve disease. Eur. Heart J. Cardiovasc. Imaging 19, 1408–1418 (2018).
van Rosendael, P. J. et al. Comparison of quantity of calcific deposits by multidetector computed tomography in the aortic valve and coronary arteries. Am. J. Cardiol. 118, 1533–1538 (2016).
Mazur, P. et al. Stenotic bicuspid and tricuspid aortic valves — micro-computed tomography and biological indices of calcification. Circ. J. 81, 1043–1050 (2017).
Naito, S., Petersen, J., Reichenspurner, H. & Girdauskas, E. The impact of coronary anomalies on the outcome in aortic valve surgery: comparison of bicuspid aortic valve versus tricuspid aortic valve morphotype. Interact. Cardiovasc. Thorac. Surg. 26, 617–622 (2018).
Johnson, A. D., Detwiler, J. H. & Higgins, C. B. Left coronary artery anatomy in patients with bicuspid aortic valves. Br. Heart J. 40, 489–493 (1978).
Koenraadt, W. M. C. et al. Coronary anatomy in Turner syndrome versus patients with isolated bicuspid aortic valves. Heart 105, 701–707 (2019).
Messner, B. & Bernhard, D. Bicuspid aortic valve-associated aortopathy: where do we stand? J. Mol. Cell. Cardiol. 133, 76–85 (2019).
Verma, S. & Siu, S. C. Aortic dilatation in patients with bicuspid aortic valve. N. Engl. J. Med. 370, 1920–1929 (2014).
Rodríguez-Palomares, J. F. et al. Aortic flow patterns and wall shear stress maps by 4D-flow cardiovascular magnetic resonance in the assessment of aortic dilatation in bicuspid aortic valve disease. J. Cardiovasc. Magn. Reson. 20, 28 (2018).
Nistri, S. et al. Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart 82, 19–22 (1999).
Fedak, P. W. M. et al. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation 106, 900–904 (2002).
Hillebrand, M. et al. Diagnostic accuracy study of routine echocardiography for bicuspid aortic valve: a retrospective study and meta-analysis. Cardiovasc. Diagn. Ther. 7, 367–379 (2017).
Cramer, P. M. & Prakash, S. K. Misclassification of bicuspid aortic valves is common and varies by imaging modality and patient characteristics. Echocardiography 36, 761–765 (2019).
Wassmuth, R., von Knobelsdorff-Brenkenhoff, F., Gruettner, H., Utz, W. & Schulz-Menger, J. Cardiac magnetic resonance imaging of congenital bicuspid aortic valves and associated aortic pathologies in adults. Eur. Heart J. Cardiovasc. Imaging 15, 673–679 (2014).
Mylotte, D. et al. Transcatheter aortic valve replacement in bicuspid aortic valve disease. J. Am. Coll. Cardiol. 64, 2330–2339 (2014).
Jilaihawi, H. et al. A bicuspid aortic valve imaging classification for the TAVR era. JACC Cardiovasc. Imaging 9, 1145–1158 (2016).
Michelena, H. I. et al. International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes. Ann. Thorac. Surg. 112, e203–e235 (2021).
Michelena, H. I. et al. Summary: international consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional, and research purposes. J. Thorac. Cardiovasc. Surg. 162, 781–797 (2021).
Hira, R. S. et al. Trends and outcomes of off-label use of transcatheter aortic valve replacement: insights from the NCDR STS/ACC TVT registry. JAMA Cardiol. 2, 846 (2017).
Hayashida, K. et al. Transcatheter aortic valve implantation for patients with severe bicuspid aortic valve stenosis. Circ. Cardiovasc. Interv. 6, 284–291 (2013).
Li, Y.-M. et al. Characteristics and outcomes following transcatheter aortic valve replacement in China: a report from China aortic valve transcatheter replacement registry (CARRY). Chin. Med. J. 134, 2678–2684 (2021).
Yoon, S.-H. et al. Clinical outcomes following transcatheter aortic valve replacement in Asian population. JACC Cardiovasc. Interv. 9, 926–933 (2016).
Li, Y. et al. Prevalence and complications of bicuspid aortic valve in Chinese according to echocardiographic database. Am. J. Cardiol. 120, 287–291 (2017).
Rao, R. S. et al. Single-center experience of 105-minimalistc transfemoral transcatheter aortic valve replacement and its outcome. Indian. Heart J. 73, 301–306 (2021).
Xiong, T.-Y. et al. Anatomical characteristics of patients with symptomatic severe aortic stenosis in China. Chin. Med. J. 134, 2738–2740 (2021).
Mentias, A. et al. Transcatheter versus surgical aortic valve replacement in patients with bicuspid aortic valve stenosis. J. Am. Coll. Cardiol. 75, 2518–2519 (2020).
Elbadawi, A. et al. Temporal trends and outcomes of transcatheter versus surgical aortic valve replacement for bicuspid aortic valve stenosis. JACC Cardiovasc. Interv. 12, 1811–1822 (2019).
Alperi, A. et al. Aortic valve replacement in low-risk patients with severe aortic stenosis outside randomized trials. J. Am. Coll. Cardiol. 77, 111–123 (2021).
Hirji, S. A. et al. Benchmarking outcomes of surgical aortic valve replacement in patients with bicuspid aortic valves: an analysis of the Society of Thoracic Surgeons database. Presented at the STS 58th Annual Meeting (2022).
Bauer, T. et al. Comparison of the effectiveness of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valves (from the German TAVI Registry). Am. J. Cardiol. 113, 518–521 (2014).
Yoon, S.-H. et al. Transcatheter aortic valve replacement with early- and new-generation devices in bicuspid aortic valve stenosis. J. Am. Coll. Cardiol. 68, 1195–1205 (2016).
Yoon, S.-H. et al. Outcomes in rranscatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis. J. Am. Coll. Cardiol. 69, 2579–2589 (2017).
Makkar, R. R. et al. Association between transcatheter aortic valve replacement for bicuspid vs tricuspid aortic stenosis and mortality or stroke. JAMA 321, 2193 (2019).
Forrest, J. K. et al. Transcatheter aortic valve replacement in bicuspid versus tricuspid aortic valves from the STS/ACC TVT registry. JACC Cardiovasc. Interv. 13, 1749–1759 (2020).
Forrest, J. K. et al. Transcatheter aortic valve replacement in low-risk patients with bicuspid aortic valve stenosis. JAMA Cardiol. 6, 50–57 (2021).
Makkar, R. R. et al. Association between transcatheter aortic valve replacement for bicuspid vs tricuspid aortic stenosis and mortality or stroke among patients at low surgical risk. JAMA 326, 1034 (2021).
Williams, M. R. et al. The PARTNER 3 bicuspid registry for transcatheter aortic valve replacement in low-surgical-risk patients. JACC Cardiovasc. Interv. 15, 523 (2022).
Mangieri, A. et al. Balloon versus self-expandable valve for the treatment of bicuspid aortic valve stenosis: insights from the BEAT international collaborative registrys. Circ. Cardiovasc. Interv. 13, e008714 (2020).
Seeger, J. et al. Significant differences in debris captured by the sentinel dual-filter cerebral embolic protection during transcatheter aortic valve replacement among different valve types. JACC Cardiovasc. Interv. 11, 1683–1693 (2018).
Fan, J. et al. Brain injury after transcatheter replacement of bicuspid versus tricuspid aortic valves. J. Am. Coll. Cardiol. 76, 2579–2590 (2020).
Lopez-Pais, J. et al. Impact of significant paravalvular leaks after transcatheter aortic valve implantation on anaemia and mortality. Heart https://doi.org/10.1136/heartjnl-2020-316941 (2020).
Jilaihawi, H. et al. A revised methodology for aortic-valvar complex calcium quantification for transcatheter aortic valve implantation. Eur. Heart J. Cardiovasc. Imaging 15, 1324–1332 (2014).
Popma, J. J. et al. Relationship of annular sizing using multidetector computed tomographic imaging and clinical outcomes after self-expanding corevalve transcatheter aortic valve replacement. Circ. Cardiovasc. Interv. 9, e003282 (2016).
Yoon, S.-H. et al. Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis. J. Am. Coll. Cardiol. 69, 2579–2589 (2017).
Kim, W.-K. et al. Determinants of paravalvular leakage following transcatheter aortic valve replacement in patients with bicuspid and tricuspid aortic stenosis. Eur. Heart J. Cardiovasc. Imaging 22, 1387–1396 (2021).
Husser, O. et al. Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable transcatheter heart valve. JACC Cardiovasc. Interv. 9, 244–254 (2016).
Siontis, G. C. M. et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J. Am. Coll. Cardiol. 64, 129–140 (2014).
Zhou, D. et al. VitaFlowTM transcatheter valve system in the treatment of severe aortic stenosis: one-year results of a multicenter study. Catheter. Cardiovasc. Interv. 95, 332–338 (2020).
Majmundar, M. et al. Meta-analysis of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valve. Am. J. Cardiol. 145, 102–110 (2021).
Hamdan, A. et al. Short membranous septum length in bicuspid aortic valve stenosis increases the risk of conduction disturbances. J. Cardiovasc. Comput. Tomogr. 15, 339–347 (2021).
Inohara, T. et al. Appropriateness of transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry. Circ. Cardiovasc. Qual. Outcomes 13, e006146 (2020).
Dowling, C., Firoozi, S. & Brecker, S. J. First-in-human experience with patient-specific computer simulation of TAVR in bicuspid aortic valve morphology. JACC Cardiovasc. Interv. 13, 184–192 (2020).
Baumgartner, H. et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur. Heart J. 38, 2739–2791 (2017).
Vahanian, A. et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur. Heart J. 43, 561–632 (2022).
Otto, C. M. et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143, e72–e227 (2021).
Willson, A. B. et al. 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J. Am. Coll. Cardiol. 59, 1287–1294 (2012).
Blanke, P. et al. Oversizing in transcatheter aortic valve replacement, a commonly used term but a poorly understood one: dependency on definition and geometrical measurements. J. Cardiovasc. Comput. Tomogr. 8, 67–76 (2014).
Dvir, D. et al. Multicenter evaluation of transcatheter aortic valve replacement using either SAPIEN XT or CoreValve: degree of device oversizing by computed-tomography and clinical outcomes. Catheter. Cardiovasc. Interv. 86, 508–515 (2015).
Buchanan, K. D. et al. Successful transcatheter aortic valve replacement in an oversized 800 mm2 annulus and bicuspid aortic valve. Cardiovasc. Revasc. Med. 19, 65–67 (2018).
Xiong, T.-Y. et al. Understanding the interaction between transcatheter aortic valve prostheses and supra-annular structures from post-implant stent geometry. JACC Cardiovasc. Interv. 12, 1164–1171 (2019).
Xiong, T.-Y. et al. Supra-annular sizing for transcatheter aortic valve replacement candidates with bicuspid aortic valve. JACC Cardiovasc. Interv. 11, 1789–1790 (2018).
Iannopollo, G. et al. Supra-annular sizing of transcatheter aortic valve prostheses in raphe-type bicuspid aortic valve disease: the LIRA method. Int. J. Cardiol. 317, 144–151 (2020).
Petronio, A. S. et al. Bicuspid aortic valve sizing for transcatheter aortic valve implantation: development and validation of an algorithm based on multi-slice computed tomography. J. Cardiovasc. Comput. Tomogr. 14, 452–461 (2020).
Liu, X. et al. Supra-annular structure assessment for self-expanding transcatheter heart valve size selection in patients with bicuspid aortic valve. Catheter. Cardiovasc. Interv. 91, 986–994 (2018).
Blackman, D. et al. Expert consensus on sizing and positioning of SAPIEN 3/ultra in bicuspid aortic valves. Cardiol. Ther. 10, 277–288 (2021).
Weir-McCall, J. R. et al. Annular versus supra-annular sizing for transcatheter aortic valve replacement in bicuspid aortic valve disease. J. Cardiovasc. Comput. Tomogr. 14, 407–413 (2020).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03495050 (2018).
Tchétché, D. New evidence in treating bicuspid TAVI patients: insights from Bivolut-X registry. https://www.youtube.com/watch?v=vswpEwlRdQ8 (2020).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02541877 (2015).
Mangieri, A. et al. Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience. EuroIntervention 14, e1269–e1275 (2018).
Makkar, R. Outcomes of transcatheter aortic valve replacement with balloon-expandable Sapien3 valve in bicuspid aortic stenosis: an analysis of the STS/ACC TVT registry. https://www.crtonline.org/presentation-detail/outcomes-of-transcatheter-aortic-valve-replacement (2019).
Blackman, D. J. et al. Clinical outcomes of the lotus valve in patients with bicuspid aortic valve stenosis: an analysis from the RESPOND study. Catheter. Cardiovasc. Interv. 93, 1116–1123 (2019).
Sá, M. P. B. O. et al. Balloon versus self-expandable transcatheter aortic valve implantation for bicuspid aortic valve stenosis: a meta-analysis of observational studies. Catheter. Cardiovasc. Interv. 98, E746–E757 (2021).
Frangieh, A. H. & Kasel, A. M. TAVI in bicuspid aortic valves ‘made easy’. Eur. Heart J. 38, 1177–1181 (2017).
Kim, W.-K. et al. Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (transcatheter heart valve embolization and migration). Eur. Heart J. 40, 3156–3165 (2019).
Halim, S. A. et al. Outcomes of transcatheter aortic valve replacement in patients with bicuspid aortic valve disease: a report from the Society of Thoracic Surgeons/American College of Cardiology transcatheter valve therapy registry. Circulation 141, 1071–1079 (2020).
Liao, Y.-B. et al. Meta-analysis of the effectiveness and safety of transcatheter aortic valve implantation without balloon predilation. Am. J. Cardiol. 117, 1629–1635 (2016).
Xu, Y.-N. et al. Balloon sizing during transcatheter aortic valve implantation: comparison of different valve morphologies. Herz 45, 192–198 (2020).
Perlman, G. Y., Blanke, P. & Webb, J. G. Transcatheter aortic valve implantation in bicuspid aortic valve stenosis. EuroIntervention 12, Y42–Y45 (2016).
Pislaru, S. V., Nkomo, V. T. & Sandhu, G. S. Assessment of prosthetic valve function after TAVR. JACC Cardiovasc. Imaging 9, 193–206 (2016).
Giannini, F. et al. Looking for optimal implantation height in bicuspid aortic valve patients undergoing transcatheter aortic valve implantation: a case series. Cardiovasc. Revasc. Med. 21, 25–27 (2020).
Eggebrecht, H. et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 8, 129–138 (2012).
Xiong, T.-Y., Martucci, G., Alosaimi, H. & Piazza, N. Ad hoc percutaneous paravalvular leak closure after transcatheter aortic valve replacement facilitated by integrated multimodality imaging. EuroIntervention 14, e526–e527 (2018).
Gurvitch, R. et al. Multislice computed tomography for prediction of optimal angiographic deployment projections during transcatheter aortic valve implantation. JACC Cardiovasc. Interv. 3, 1157–1165 (2010).
Sarkar, K., Ussia, G. P. & Tamburino, C. Trans catheter aortic valve implantation with core valve revalving system in uncoiled (horizontal) aorta. overcoming anatomical and technical challenges for successful deployment. Catheter. Cardiovasc. Interv. 78, 964–969 (2011).
Noble, S. & Roffi, M. Retrograde aortic valve crossing of the corevalve prosthesis using the buddy balloon technique. Catheter. Cardiovasc. Interv. 84, 897–899 (2014).
Choudhury, T., Solomonica, A. & Bagur, R. The ACURATE neo transcatheter aortic valve system. Expert. Rev. Med. Devices 15, 693–699 (2018).
Hiratzka, L. F. et al. Surgery for aortic dilatation in patients with bicuspid aortic valves. J. Am. Coll. Cardiol. 67, 724–731 (2016).
Rylski, B. et al. Transcatheter aortic valve implantation in patients with ascending aortic dilatation: safety of the procedure and mid-term follow-up. Eur. J. Cardiothorac. Surg. 46, 228–233 (2014).
Jacobzon, E., Wolak, A., Fink, D. & Silberman, S. Delayed aortic dissection and valve thrombosis after transcatheter aortic valve implantation. Catheter. Cardiovasc. Interv. 93, E391–E393 (2019).
Fuchs, A. et al. Subclinical leaflet thickening and stent frame geometry in self-expanding transcatheter heart valves. EuroIntervention 13, e1067–e1075 (2017).
Lv, W.-Y. et al. Progression of the ascending aortic diameter after transcatheter aortic valve implantation: based on computed tomography images. J. Invasive Cardiol. 31, E234–E241 (2019).
He, Y.-X. et al. Ascending aortic dilatation rate after transcatheter aortic valve replacement in patients with bicuspid and tricuspid aortic stenosis: a multidetector computed tomography follow-up study. World J. Emerg. Med. 10, 197–204 (2019).
Gunning, P. S., Saikrishnan, N., Yoganathan, A. P. & McNamara, L. M. Total ellipse of the heart valve: the impact of eccentric stent distortion on the regional dynamic deformation of pericardial tissue leaflets of a transcatheter aortic valve replacement. J. R. Soc. Interface 12, 20150737 (2015).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02825134 (2021).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02628899 (2022).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03635424 (2022).
Kochman, J. et al. Comparison of one- and 12-month outcomes of transcatheter aortic valve replacement in patients with severely stenotic bicuspid versus tricuspid aortic valves (results from a multicenter registry). Am. J. Cardiol. 114, 757–762 (2014).
Himbert, D. et al. Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves. Am. J. Cardiol. 110, 877–883 (2012).
Costopoulos, C. et al. Comparison of results of transcatheter aortic valve implantation in patients with severely stenotic bicuspid versus tricuspid or nonbicuspid valves. Am. J. Cardiol. 113, 1390–1393 (2014).
Mack, M. J. et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA 310, 2069–2077 (2013).
Acknowledgements
We thank the National Natural Science Foundation of China (81970325, 82170375 and 82102129) and West China Hospital “1·3·5” Discipline of Excellence Project — “Percutaneous transcatheter aortic valve implantation” and “Mechanisms of aortic stenosis and the clinical applications” for supporting this project, and Yi Zhang (Department of Cardiology, West China Hospital, Sichuan University, China) for assistance with the literature review.
Author information
Authors and Affiliations
Contributions
In the author list, the authors from W.B. to W.-H.Y. are listed in alphabetical order by surname. All the authors participated in the Delphi development and evaluation process, which was coordinated by T.-Y.X. and M.C. T.-Y.X. and D.M. wrote the first draft of the Introduction. T.-Y.X. wrote the first draft of the Methodology. T.-Y.X. and A.S. wrote the first draft of the ‘Morphology and anatomy’ section. T.-Y.X. and K.H. wrote the first draft of the ‘Diagnosis and classification’ section. T.-Y.X., W.B., T.M. and L.S. wrote the first draft of the ‘Choice of treatment’ section. T.-Y.X. and N.P. wrote the first draft of the ‘TAVI sizing in BAV’ section. T.-Y.X. and S.R. wrote the first draft of the ‘Device selection’ section. T.-Y.X. and D.T. wrote the first draft of the ‘Intra-procedural considerations’ section. T.-Y.X. and A.L. wrote the first draft of the ‘Post-procedural management’ section. All the sections were edited by M.C., B.P. and D.M. before final review and revision by all the authors. Authors from different regions were encouraged to report local practices during the revisions.
Corresponding authors
Ethics declarations
Competing interests
Y.F. is a consultant/proctor for Peijia Medical and Venus MedTech. K.H. is a proctor for Edwards Lifesciences and Medtronic. H.J. is a consultant to Boston Scientific, Edwards Lifesciences and Medtronic, and has received grant and research support from Abbott Vascular, Edwards Lifesciences and Medtronic. A.L. is an advisory board member for Abbott and Medtronic. M.K.-Y.L. is a proctor for Edwards Lifesciences and Medtronic. M.B.L. has received institutional research support from Abbott, Boston Scientific, Edwards Lifesciences and Medtronic, and is a consultant or advisory board member for Abbott, Boston Scientific, Gore, Medtronic and Meril Life. R.R.M. has received research grants from Abbott, Boston Scientific, Edwards Lifesciences and Medtronic, and has received personal fees from Edwards Lifesciences for travel. T.M. is a consultant for Abbott, Boston Scientific, Cephea, Edwards Lifesciences, GE Healthcare, Medtronic and Microport, is a proctor for Medtronic, and receives speaker fees from Medtronic. C.N. has received lecture fees from Abbott Vascular, Boston Scientific and Medtronic, and has served on the advisory boards of Abbott Vascular and Boston Scientific. N.P. is a consultant and proctor for Medtronic and Peijia Medical. M.J.R. serves on an advisory board for Medtronic. S.R. has received speaker fees from Edwards Lifesciences and has served as an international advisory board member for Medtronic. A.S. is an adviser/speaker for Abbott Vascular, Boston Scientific, Medtronic and Meril Lifesciences, and is a proctor for Medtronic and Meril Lifesciences. L.S. has received consulting fees and institutional research grants from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic and Symetis. D.T. is a proctor for Boston Scientific, Edwards Lifesciences and Medtronic. M.C. is a consultant/proctor for Peijia Medical and Venus MedTech. B.P. has received institutional educational and research grants from Edwards Lifesciences and has received speaker/consultancy fees from Abbott, Anteris, Edwards Lifesciences, Medtronic and Microport. D.M. is a proctor and consultant for Medtronic and Microport and is a consultant for Boston Scientific. The other authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Cardiology thanks Arturo Evangelista, Philippe Pibarot and Flavien Vincent for their contribution to the peer review of this work. Nature Reviews Cardiology also thanks Ottavio Alfieri, who co-reviewed with Nicola Buzzatti; Nicolas van Mieghem; and the other, anonymous, reviewer(s) for their contribution to the peer review of a previous version of this work.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Xiong, TY., Ali, W.B., Feng, Y. et al. Transcatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization. Nat Rev Cardiol 20, 52–67 (2023). https://doi.org/10.1038/s41569-022-00734-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-022-00734-5